Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CASP6 | P55212 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11376657 | 0.80 | LMNA (0.43) | LMNAMEN1KMT2APOLBCASP6 | |
| SCHEMBL3869264 | 0.73 | ATM (0.47) | MEN1KMT2APOLBCASP6ALDH1A1 | |
| SCHEMBL11695234 | 0.71 | MEN1 (0.47) | LMNAMEN1KMT2APOLBCASP6 | |
| SCHEMBL11883261 | 0.71 | LMNA (0.39) | LMNA | |
| SCHEMBL11883266 | 0.71 | LMNA (0.39) | LMNA | |
| SCHEMBL11128291 | 0.70 | LMNA (0.50) | LMNAMEN1KMT2APOLBCASP6 | |
| Carbamic Acid SCHEMBL20269740 | 0.70 | KMT2A (0.50) | LMNAMEN1KMT2APOLBCASP6 | |
| SCHEMBL6251001 | 0.69 | ALDH1A1 (0.43) | MEN1KMT2AALDH1A1ALOX15HCAR2 | |
| SCHEMBL10574669 | 0.68 | BCL2 (0.37) | LMNAMEN1KMT2APOLBCASP6 | |
| SCHEMBL7703178 | 0.68 | MEN1 (0.40) | MEN1KMT2AALDH1A1DAOTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040097554-A1 | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents | PFIZER INC | 2004-05-20 | — | — | US | claimed |
| US-20040097554-A1 | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents | PFIZER INC | 2004-05-20 | — | — | US | disclosed |
| US-5840962-A | IN SOLVENT USING ACID CATALYST; BY-PRODUCT INHIBITION | INDUSTRIAS MONFEL S.A. DE C.V. (MX) | 1998-11-24 | — | — | US | disclosed |
| US-4039540-A | BACTERICIDES, ANIMAL GROWTH PROMOTERS | PFIZER INC. (US) | 1977-08-02 | — | — | US | disclosed |
| US-4007184-A | BACTERICIDE, ANIMAL GROWTH REGULATOR | PFIZER INC. (US) | 1977-02-08 | — | — | US | disclosed |
| US-4007184-A | BACTERICIDE, ANIMAL GROWTH REGULATOR | PFIZER INC. (US) | 1977-02-08 | — | — | US | disclosed |
| US-3948911-A | ANTIBACTERIAL, ANIMAL GROWTH REGULATORS | PFIZER INC. (US) | 1976-04-06 | — | — | US | disclosed |
| US-3915975-A | Substituted alkyl esters of quinoxaline-di-N-oxide-2-carboxylic acid | PFIZER | 1975-10-28 | — | — | US | disclosed |
| US-3915975-A | Substituted alkyl esters of quinoxaline-di-N-oxide-2-carboxylic acid | PFIZER | 1975-10-28 | — | — | US | disclosed |
| US-3907994-A | Substituted alkyl esters quinoxaline-di-N-oxide-2-carboxylic acid as growth promoting agents | PFIZER | 1975-09-23 | — | — | US | disclosed |
| US-3818007-A | HYDROXYALKYL ESTERS OF QUINOXALINE-DI-N-OXIDE-2-CARBOXYLIC ACID | PFIZER | 1974-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097554-A1 | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents | CCR1, HCAR1, CCR3 | LMNA 4457/4885MEN1 3377/4885KMT2A 4284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.